(Q46694910)

English

PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

1 reference

based on heuristic

inferred from title

author name string

Graham P Holloway

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

Christopher G R Perry

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

A Brianne Thrush

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

George J F Heigenhauser

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

David J Dyck

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

Arend Bonen

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

Lawrence L Spriet

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

publication date

18 March 2008

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

294

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

E1060-9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Energy balance and food intake: the role of PPARgamma gene polymorphisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Transcriptional regulatory circuits controlling mitochondrial biogenesis and function

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

PGC-1beta in the regulation of hepatic glucose and energy metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Overexpression of peroxisome proliferator-activated receptor gamma coactivator-1alpha down-regulates GLUT4 mRNA in skeletal muscles

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Alterations in soleus muscle gene expression associated with a metabolic endpoint following exercise training by lean and obese Zucker rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Activation of PPARgamma coactivator-1 through transcription factor docking

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Nuclear activators and coactivators in mammalian mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

What is the biological significance of the two mitofusin proteins present in the outer mitochondrial membrane of mammalian cells?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00726.2007

21 January 2018

Identifiers

10.1152/AJPENDO.00726.2007

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18349111

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46694910&oldid=2127245629"